Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-27

Clinical Trial Update: A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding [Phase 4]

View source ↗

Summary

Phase 4 study assessing whether famciclovir reduces genital herpes virus shedding; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famciclovir (Famvir) (famciclovir)

Snippet

Sponsor: Novartis | Conditions: Genital Herpes | Phase 4 | Status: COMPLETED